Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, ...

Shaelyn Weaver says she learned to take pride in her appearance: “I finally saw myself as the girl I wanted to be” ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Melissa Floro, 38, opened up to PEOPLE about how much her life has changed since turning to Ozempic for weight loss and ...

Study finds GLP-1 medications such as Ozempic could result in cuts to grocery spending and reductions in spending at ...

Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

President-elect Donald Trump has chosen two prominent men to lead health-related affairs in his administration, Mehmet Oz, MD, and Robert Kennedy, Jr. While the two leaders will be leading health ...

For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are ...